Sandbox 645

From Proteopedia

(Difference between revisions)
Jump to: navigation, search
Line 78: Line 78:
The main goals for future research in this field are:
The main goals for future research in this field are:
-
i)the design of better pharmacological agents and avoid severe side effects
+
 
-
ii)achieving era direction of the virus and possibly definitive cure of the disease..
+
i) The design of better pharmacological agents while also avoiding severe side effects.
 +
 
 +
ii) Achieving eradication of the virus and possibly a definitive cure for those infected.
 +
 
As has been mentioned previously, the pol gene of HIV-1 encodes for three enzymes; protease (PR), reverse transcriptase (RT) and integrase (IN). More than 10 drugs targeting two of these enzymes, PR and RT, have been approved by the FDA. At present, there are no clinically useful agents that inhibit the third enzyme, integrase. Researchers are trying to emphasize the proposed drug binding sites on IN in order to find successfully binding inhibitors. This, along with continued research into inhibition design with HIV-1 Protease, will add to the foundation of research into defeating HIV.
As has been mentioned previously, the pol gene of HIV-1 encodes for three enzymes; protease (PR), reverse transcriptase (RT) and integrase (IN). More than 10 drugs targeting two of these enzymes, PR and RT, have been approved by the FDA. At present, there are no clinically useful agents that inhibit the third enzyme, integrase. Researchers are trying to emphasize the proposed drug binding sites on IN in order to find successfully binding inhibitors. This, along with continued research into inhibition design with HIV-1 Protease, will add to the foundation of research into defeating HIV.

Revision as of 13:38, 27 November 2012

HIV-1 Protease

Structure of HIV-1 Protease (PDB entry 2nmz)

Drag the structure with the mouse to rotate
Personal tools